Terms: = Skin cancer AND SMARCA4, hSNF2b, 6597, P51532, BRG1, SNF2L4, SNF2, SWI2, FLJ39786, BAF190, SNF2LB, SNF2-BETA, ENSG00000127616 AND Diagnosis
5 results:
1. PRAME immunohistochemistry in soft tissue tumors and mimics: a study of 350 cases highlighting its imperfect specificity but potentially useful diagnostic applications.
Cammareri C; Beltzung F; Michal M; Vanhersecke L; Coindre JM; Velasco V; Le Loarer F; Vergier B; Perret R
Virchows Arch; 2023 Aug; 483(2):145-156. PubMed ID: 37477762
[TBL] [Abstract] [Full Text] [Related]
2. Primary cutaneous smarca4-deficient undifferentiated malignant neoplasm: first two cases with clinicopathologic and molecular comparison to eight visceral counterparts.
Russell-Goldman E; MacConaill L; Hanna J
Mod Pathol; 2022 Dec; 35(12):1821-1828. PubMed ID: 36085356
[TBL] [Abstract] [Full Text] [Related]
3. smarca4 (brg1) loss of expression is a useful marker for the diagnosis of ovarian small cell carcinoma of the hypercalcemic type (ovarian rhabdoid tumor): a comprehensive analysis of 116 rare gynecologic tumors, 9 soft tissue tumors, and 9 melanomas.
Karanian-Philippe M; Velasco V; Longy M; Floquet A; Arnould L; Coindre JM; Le Naoures-Méar C; Averous G; Guyon F; MacGrogan G; Croce S
Am J Surg Pathol; 2015 Sep; 39(9):1197-205. PubMed ID: 26135561
[TBL] [Abstract] [Full Text] [Related]
4. Rhabdoid tumor predisposition syndrome.
Sredni ST; Tomita T
Pediatr Dev Pathol; 2015; 18(1):49-58. PubMed ID: 25494491
[TBL] [Abstract] [Full Text] [Related]
5. Novel multiple markers to distinguish melanoma from dysplastic nevi.
Zhang G; Li G
PLoS One; 2012; 7(9):e45037. PubMed ID: 23028750
[TBL] [Abstract] [Full Text] [Related]
